Cutaneous sarcoidosis therapy updated - 12/08/11
Houston, Texas
Abstract |
The widely accepted standard therapy for cutaneous sarcoidosis includes corticosteroids, antimalarials, and methotrexate. However, a better understanding of the basic immunopathogenic properties of sarcoidosis has elucidated a number of steps critical to the persistence and progression of disease that may be vulnerable to treatment by targeted therapy. This article reviews both standard and newer therapeutic options for cutaneous sarcoidosis.
Le texte complet de cet article est disponible en PDF.Abbreviations used : APC, FDA, ICAM-1, IFN-γ, IL, MGC, TNF⍺
Plan
Funding sources: None. Conflicts of interest: None identified. Reprints not available from the authors. |
Vol 56 - N° 1
P. 69-83 - janvier 2007 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?